In 2021, manufacturers boosted the cost of seven of the country’s most expensive drugs by more than $805 million without any evidence supporting the price hikes, the Institute for Clinical and Evidence Review (ICER) reports in its latest annual cost analysis.
Source: Drug Industry Daily